Professor Mahmoud Shaker Khudair participated in the Baghdad Scientific Dialogue Conference on Insulin Therapy.
Professor Mahmoud Shaker Khudair participated in the scientific conference "Baghdad Dialogue," organized by the global company Novo Nordisk in collaboration with the Iraqi Association for Diabetes and Endocrinology in Baghdad recently.
Professor Mahmoud Shaker delivered a lecture on the importance of insulin therapy, emphasizing its vital role as a lifesaving treatment for patients with type 1 diabetes and its significance as a primary treatment for type 2 diabetes in preventing chronic complications. He also highlighted the latest types of insulin, noting their superiority in reducing the risk of hypoglycemia, thus enhancing the safety and effectiveness of the treatment.
The conference witnessed wide participation from professors, doctors, pharmacists, and individuals interested in diabetes treatment, contributing to the exchange of expertise and discussion of the latest developments in diabetes and insulin therapy.
